Last10K.com

Affimed N.V. (AFMD) SEC Filing 20-F Annual report for the fiscal year ending Tuesday, December 31, 2019

SEC Filings

AFMD Valuations

Intrinsic Value
Financial Stability
Financial Ratios
Insider Trades
Manager Portfolios
Notifications

AFMD Annual Reports

AFMD Corporate News

Affimed N.V.

HISTORY TOOLS
CIK: 1608390 Ticker: AFMD

View differences made from one year to another to evaluate Affimed N.V.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 20-F Annual Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Affimed N.V..

Continue

Assess how Affimed N.V.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Affimed N.V.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2020 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

SEC Filing Tools

Financial Statements, Disclosures and Schedules

Inside this 20-F Annual Report

Document And Entity Information
Consolidated Statement Of Cash Flows
Consolidated Statement Of Changes In Equity
Consolidated Statements Of Comprehensive Loss
Consolidated Statements Of Financial Position
1. Reporting Entity
10. Employee Benefits
10. Employee Benefits (Details)
10. Employee Benefits (Tables)
10. Employee Benefits - Narrative (Details)
11. Finance Income And Finance Costs
11. Finance Income And Finance Costs (Details)
11. Finance Income And Finance Costs (Tables)
12. Income Taxes
12. Income Taxes (Details)
12. Income Taxes (Tables)
12. Income Taxes - Narrative (Details)
13. Long Term Financial Assets
13. Long Term Financial Assets (Details)
14. Financial Assets
14. Financial Assets (Details)
15. Trade And Other Receivables
15. Trade And Other Receivables (Details)
16. Equity
16. Equity (Details)
17. Share Based Payments
17. Share Based Payments (Details)
17. Share Based Payments (Tables)
17. Share Based Payments - Narrative (Details)
18. Provisions
18. Provisions (Details)
19. Borrowings
19. Borrowings (Details)
19. Borrowings (Tables)
19. Borrowings - Movements Of Liabilities Reconcile To Cash Flows Arising From Financing Activities (Details)
19. Borrowings - Narrative (Details)
2. Local Exemption Rules Applied By Subsidiaries Of The Group
20. Trade And Other Payables
20. Trade And Other Payables (Details)
21. Leases
21. Leases (Tables)
21. Leases - Future Contractually Agreed Undiscounted Lease Payments (Details)
21. Leases - Movements Of Lease Liabilities (Details)
21. Leases - Narrative (Details)
21. Leases - Schedule Of Carrying Amounts Of Right-Of-Use Assets Reconcile (Details)
21. Leases - Schedule Of Cash Outflow Related To Leases (Details)
22. Other Commitments And Contingencies
22. Other Commitments And Contingencies - Narrative (Details)
23. Related Parties
23. Related Parties (Tables)
23. Related Parties - Compensation (Details)
23. Related Parties - Narrative (Details)
23. Related Parties - Outstanding Balances (Details)
24. Financial Risk Management
24. Financial Risk Management (Tables)
24. Financial Risk Management - Exchange Rates (Details)
24. Financial Risk Management - Narrative (Details)
25. Subsequent Events
3. Basis Of Preparation ??? Consolidated Financial Statements
4. Significant Accounting Policies
4. Significant Accounting Policies (Details)
4. Significant Accounting Policies (Policies)
4. Significant Accounting Policies (Tables)
4. Significant Accounting Policies - Narrative (Details)
4. Significant Accounting Policies -Lease (Details)
5. Segment Reporting
5. Segment Reporting (Tables)
5. Segment Reporting - Geographic Information (Details)
5. Segment Reporting - Narrative (Details)
6. Revenue
6. Revenue (Details)
6. Revenue (Tables)
6. Revenue - Disaggregation Of Revenue (Details)
6. Revenue - Narrative (Details)
7. Other Income And Expenses - Net
7. Other Income And Expenses - Net (Details)
8. Research And Development Expenses
8. Research And Development Expenses (Details)
8. Research And Development Expenses (Tables)
9. General And Administrative Expenses
9. General And Administrative Expenses (Details)
9. General And Administrative Expenses (Tables)
Ticker: AFMD
CIK: 1608390
Form Type: 20-F Annual Report
Accession Number: 0001558370-20-004500
Submitted to the SEC: Tue Apr 28 2020 5:02:38 PM EST
Accepted by the SEC: Tue Apr 28 2020
Period: Tuesday, December 31, 2019
Industry: Pharmaceutical Preparations

External Resources:
Stock Quote
Social Media
SEC.gov

Bookmark the Permalink:
https://last10k.com/sec-filings/afmd/0001558370-20-004500.htm